Expert Discusses New Specialty Drugs That are in the Pipeline
June 12th 2022Aimee Banks, PharmD, BCPS, MSCS, clinical pharmacist in the Multiple Sclerosis Clinic at Vanderbilt University Medical Center, discusses new hematology, oncology, and autoimmune therapies in the pipeline that pharmacists should be aware of.
Watch
Study: JZP458 Shows Positive Benefit in Acute Lymphoblastic Leukemia, Lymphoblastic Lymphoma
June 9th 2022JZP458, a recombinant Erwinia-derived ASNase from a Pseudomonas fluorescens expression platform, was previously approved by the FDA for patients with ALL/LBL who had developed hypersensitivity to Escherichia coli (E. coli)–derived ASNase.
Read More